Clinical potential of nintedanib for the second-line treatment of advanced non-small-cell lung cancer: current evidence

Sacha Rothschild
  • Lung Cancer Targets and Therapy, September 2014, Taylor & Francis
  • DOI: 10.2147/lctt.s49490

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.2147/lctt.s49490